DKK 7.0
(1.74%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -3.49 DKK | -52.4% |
2022 | -2.29 DKK | 46.99% |
2021 | -4.32 DKK | 7.89% |
2020 | -4.69 DKK | 1.88% |
2019 | -4.78 DKK | 16.58% |
2018 | -5.73 DKK | -111.44% |
2017 | -2.71 DKK | -44.15% |
2016 | -1.88 DKK | -32.58% |
2015 | -1.42 DKK | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.64 DKK | -14.29% |
2024 Q1 | -0.56 DKK | -9.8% |
2023 FY | - DKK | -52.4% |
2023 Q3 | -0.49 DKK | 42.35% |
2023 Q1 | -0.68 DKK | -65.85% |
2023 Q2 | -0.85 DKK | -25.0% |
2023 Q4 | -0.51 DKK | -4.08% |
2022 Q1 | -0.94 DKK | 27.13% |
2022 FY | - DKK | 46.99% |
2022 Q4 | -0.41 DKK | 53.93% |
2022 Q3 | -0.89 DKK | -45.9% |
2022 Q2 | -0.61 DKK | 35.11% |
2021 Q2 | -1.62 DKK | -14.89% |
2021 Q1 | -1.41 DKK | 0.7% |
2021 FY | - DKK | 7.89% |
2021 Q4 | -1.29 DKK | 6.52% |
2021 Q3 | -1.38 DKK | 14.81% |
2020 Q3 | -1.22 DKK | 14.69% |
2020 Q1 | -2.04 DKK | 8.93% |
2020 Q4 | -1.42 DKK | -16.39% |
2020 Q2 | -1.43 DKK | 29.9% |
2020 FY | - DKK | 1.88% |
2019 Q2 | -1.43 DKK | -18.18% |
2019 FY | - DKK | 16.58% |
2019 Q4 | -2.24 DKK | -69.7% |
2019 Q3 | -1.32 DKK | 7.69% |
2019 Q1 | -1.21 DKK | -1.68% |
2018 Q4 | -1.19 DKK | -54.55% |
2018 Q3 | -0.77 DKK | 80.1% |
2018 Q1 | -1.05 DKK | -110.0% |
2018 Q2 | -3.87 DKK | -268.57% |
2018 FY | - DKK | -111.44% |
2017 Q1 | -0.36 DKK | 0.0% |
2017 Q3 | -0.66 DKK | 29.79% |
2017 Q2 | -0.94 DKK | -161.11% |
2017 FY | - DKK | -44.15% |
2017 Q4 | -0.50 DKK | 24.24% |
2016 FY | - DKK | -32.58% |
2015 FY | - DKK | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Ambu A/S | 0.88 DKK | 496.591% |
ChemoMetec A/S | 7.83 DKK | 144.572% |
Demant A/S | 8.04 DKK | 143.408% |
GN Store Nord A/S | 1.64 DKK | 312.805% |
Scandinavian Medical Solutions A/S | 0.45 DKK | 875.556% |